Connect with us

Hi, what are you looking for?


4th COVID vaccine dose significantly boosts immunity, UK study finds

LONDON — A fourth dose of an mRNA vaccine significantly boosts the immune protection from the coronavirus in all ages, according to new research published Tuesday in the Lancet Infectious Diseases journal.

Researchers tested the antibody and cellular immune responses in people who had previously had three doses of the BioNTech/Pfizer vaccine and those who had received two doses of the Oxford/AstraZeneca jab plus a third shot with BioNTech/Pfizer.

Half the people in each group were given another Pfizer jab, the others were given the Moderna half-dose booster, around 30 weeks after their third shot.

Results from the extended COV-BOOST study found that those who received the Moderna jab saw the highest boost to their immunity with around a 16-fold increase compared with before the fourth shot.

Also, compared with 28 days after their third jab (when the immune response is highest), the Moderna booster on average more than doubled the level of antibodies against the spike protein.

There was also a significant boost to immunity with a fourth dose of the BioNTech/Pfizer jab. Antibody levels increased on average 12-fold compared with before the dose, and by more than one-and-a-half times compared with 28 days after their third shot.

The data also hint at a ceiling of antibody levels from boosting with both mRNA vaccines, the researchers found.

The results come as countries continue to expand their booster programs to older and more vulnerable groups, in whom waning protection poses greater risks.

While the European Medicines Agency has endorsed a fourth dose in vulnerable and immunocompromised people, no vaccines have yet been authorized as a second booster in the general population.

Asked during a press briefing Monday whether the data supported boosting wider populations, Saul Faust, COV-BOOST chief investigator, said that decision would be for immunization committees and will be based on rates of hospitalizations and severe disease among those who’ve received two and three doses, as well as emerging variants.

He said current vaccines were continuing to protect people well from severe disease, even in people who have received three doses of the AstraZeneca vaccine, which has shown to generate lower antibody levels.

Click to comment

Leave a Reply

Your email address will not be published.

You May Also Like


LONDON — Photographs which appear to show U.K. Prime Minister Boris Johnson drinking at a potentially rule-breaking party have been published by ITV News....


Carl Bildt is the former prime minister and foreign minister of Sweden and the co-chair of the European Council on Foreign Relations. Russia’s illegal...


Press play to listen to this article MARSEILLE, France — Sitting in a café in Marseille, the firebrand leader of the left, Jean-Luc Mélenchon,...


Belgium has become the first country to introduce a compulsory 21-day quarantine for monkeypox patients after reporting four cases of the disease in the...


Having settled in Brussels after three decades reporting about the broader Middle East, Hugh Pope is preparing for publication “The Keys to Democracy,” a...


Canada has targeted media tycoon Alexander Lebedev as part of a wave of fresh sanctions against Russian oligarchs, in a move that places greater...


Australian Labor Party leader Anthony Albanese will be the country’s new prime minister, following incumbent Scott Morrison’s failure to win enough seats for the...


Moldova’s defenses should be bolstered to help guard against Russian President Vladimir Putin’s vision for an expanded Russia in Eastern Europe, U.K. Foreign Secretary...